chr6-5261075-T-G
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The ENST00000324331.10(FARS2):c.-305T>G variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00827 in 451,680 control chromosomes in the GnomAD database, including 114 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.020 ( 91 hom., cov: 34)
Exomes 𝑓: 0.0022 ( 23 hom. )
Consequence
FARS2
ENST00000324331.10 5_prime_UTR
ENST00000324331.10 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.23
Genes affected
FARS2 (HGNC:21062): (phenylalanyl-tRNA synthetase 2, mitochondrial) This gene encodes a protein that transfers phenylalanine to its cognate tRNA. This protein localizes to the mitochondrion and plays a role in mitochondrial protein translation. Mutations in this gene can cause combined oxidative phosphorylation deficiency 14 (Alpers encephalopathy). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.0).
BP6
Variant 6-5261075-T-G is Benign according to our data. Variant chr6-5261075-T-G is described in ClinVar as [Benign]. Clinvar id is 1233400.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0667 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FARS2 | NM_001318872.2 | c.-305T>G | 5_prime_UTR_variant | 1/7 | |||
FARS2 | NM_001374878.1 | c.-338T>G | 5_prime_UTR_variant | 1/7 | |||
FARS2 | XM_047418087.1 | c.-305T>G | 5_prime_UTR_variant | 1/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FARS2 | ENST00000324331.10 | c.-305T>G | 5_prime_UTR_variant | 1/7 | 1 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0203 AC: 3082AN: 152124Hom.: 91 Cov.: 34
GnomAD3 genomes
AF:
AC:
3082
AN:
152124
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00218 AC: 652AN: 299440Hom.: 23 Cov.: 6 AF XY: 0.00203 AC XY: 291AN XY: 143242
GnomAD4 exome
AF:
AC:
652
AN:
299440
Hom.:
Cov.:
6
AF XY:
AC XY:
291
AN XY:
143242
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0203 AC: 3083AN: 152240Hom.: 91 Cov.: 34 AF XY: 0.0193 AC XY: 1438AN XY: 74436
GnomAD4 genome
AF:
AC:
3083
AN:
152240
Hom.:
Cov.:
34
AF XY:
AC XY:
1438
AN XY:
74436
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
30
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 14, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at